After treatment with semaglutide, newly diagnosed Type 1 diabetes patients needed little or no insulin
Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.